tirzepatide surpass trials New research from the SURPASS-EARLY trial found that improved glycemic control, body weight, and waist circumference over 104 weeks compared with intensified conventional care in adults with early type 2 diabetes 💡 New insight in diabetes

Start your intake When Does Semaglutide Start Working for Weight Loss

In general, oral semaglutide for weight management is appropriate for adults with a BMI of 30 or above (obesity), or a BMI of 27 or above alongside a weight-related health condition such as type 2 diabetes, high blood pressure, or elevated cholesterol

Side effects and safety considerations The most common side effects of GLP-1 medications are gastrointestinal and include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort

Nasal bioavailability is approximately 3%

NAC is also an approved drug ingredient for specific medical uses